Subscribe to Search results

The commercial heat-treated Factor 8 product used at Birmingham Children's Hospital in 1985 and 1986 was Armour's product.

Published on:

Armour had been the sole supplier of heat-treated Factor 8 to the region up to the point at which it was discovered that previously HIV negative children at Birmingham Children's Hospital treated with heated Factorate had been infected with HIV.

Published on:

Armour made regular financial contributions to Dr Hill's "research fund".

Published on:

Dr Hill continued to screen children for HTLV-3 antibodies, that just over 50% were positive and that Dr Hill suspected that all children who have had a long exposure to concentrate may well have been infected.

Published on:

In a report prepared by Dr Franklin and Dr Hill, it was reported that 60% of the patients at BCH were positive for HIV.

Published on:

Dr Hill reported to Armour that two children had seroconverted to HIV following their use of Armour heat-treated Factorate.

Published on:

Of two boys who had seroconverted, Dr Hill stated that number 2 was treated with NHS product only, and number 1 was just unlucky as they had had only a moderate amount of treatment.

Published on:

Dr Hill reported to Armour that a third child had seroconverted.

Published on:

The Royal Manchester Children's Hospital treated children up to the age of 16 or 17 years.

Published on:

There was a smaller centre at Booth Hall Children's Hospital, where Dr Evans was the director and small numbers of patients were treated each year

Published on:

Letters were sent out to parents with their children's AIDS test results. There is also some evidence of two group meetings for parents being held at the RMCH.

Published on:

Dr Evans was concerned about the transmissibility of hepatitis to write to Professor Blackburn (then chair of UKHCDO) wanting to know what different laboratories were doing.

Published on:

In 1976 the annual returns from the Royal Manchester Childrens' Hospital showed the use of 270,970 units of cryoprecipitate, 32,973 units of commercial concentrates and 3,535 units of NHS Factor 8.

Published on:

By 1979 for the first time more units of concentrates (predominantly commercial) were used than cryoprecipitate at the Royal Manchester Childrens' Hospital .

Published on:

In 1980 significantly more units of concentrates (predominantly commercial) were used than cryoprecipitate at the Royal Manchester Childrens' Hospital.

Published on:

Inquiry issues letter about monitoring liver damage

Published on:

Richard Gutowski had expressed his concerns to Charles Dobson that "Officials would accordingly advise strongly against an out of court settlement in the HIV/haemophiliacs litigation."

Published on:

Inquiry issues letter about siblings and compensation

Published on:

Infected Blood Inquiry to Publish Additional Report

Published on:

Targets for blood donations were generally set up by BPL rather than being set by RTCs, resulting in push back from RTCs as they believed that the level that was set was not correct.

Published on: